Commercialization: Page 89
-
PharmaVoice Team/PharmaVoice
Who's on the List - 2008 - By section
July / August 2008 PharmaVOICE The PHARMAVOICE 100 Jeffrey S. Aronin Ovation Pharmaceuticals Inc. Gerianne T. DiPiano FemmePharma Global Healthcare Inc. Chris Porter Clinipace Inc. Kathleen Drennan Iris Global Clinical Trial Solutions Jason Appel SanofiAventis Adriann Sax King Pharmaceuticals Inc...
By PharmaVoice Team • July 24, 2008 -
PharmaVoice Team/PharmaVoice
Clinical Operations: Bringing All of the Pieces Together
6 June 20 08 VIEW on Clinical Operations THE FORUM A recentTufts CSDD study cites research showing that the cost to develop a new biopharmaceutical is now more than $1 billion. Accordingly, clinical organizations are under growing pressure to reduce research and development costs while accelerati...
By PharmaVoice Team • June 9, 2008 -
PharmaVoice Team/PharmaVoice
Evaluating and Allocating Advertising Budgets: A Sponsor's Responsibility
36 June 20 08 VIEW on Clinical Operations PATIENT RECRUITMENT E valuating and allocating costefficient, yet costeffective advertising bud gets for a patient recruiting campaign is an issue that rarely receives the attention it deserves. A wellplanned budget is absolutely integral to the success o...
By PharmaVoice Team • June 9, 2008 -
PharmaVoice Team/PharmaVoice
Avoiding the Five Common Errors Made in Implementing a CTMS
22 June 20 08 VIEW on Clinical Operations ECLINICAL I n recent years, the management of clinical trials has become increasing ly complex as the size, geographic diversity, and complexity of trials grows. Managing these highly complex trials requires the study manag er to be in control of a wide r...
By PharmaVoice Team • June 9, 2008 -
PharmaVoice Team/PharmaVoice
Supplier Showcase
Showcase 42 June 20 08 VIEW on Clinical Operations Ateb Inc. 4501 Atlantic Ave. Ste. 110 Raleigh, NC 27604 Phone: 9198824935 www.ateb.com Pharmacy Outreach via Patient Messaging Solutions Ateb provides Pharmacy Outreach through our Patient Messaging Solutions; a unique inbound and outbound bridge...
By PharmaVoice Team • June 9, 2008 -
PharmaVoice Team/PharmaVoice
Mass Customization of Physician Messaging
While the pharmaceutical industry cannot adopt mass customization in the manufacture of its products, it can adopt mass customization in the marketing of its products to physicians, enabling sales reps to impart added value in presenting product information to the customer: physicians. Research s...
By PharmaVoice Team • May 28, 2008 -
PharmaVoice Team/PharmaVoice
DIA Preview Showcase
SPECIAL FEATURE DIA 44TH ANNUAL MEETING Representing more than 20,000 members worldwide involved in discovery, development, regulation, and marketing of bio/phar maceutical and related products, the Drug Information Association (DIA) each year has the significant task of designing an annual meeti...
By PharmaVoice Team • May 28, 2008 -
PharmaVoice Team/PharmaVoice
Redefining the Salesforce Landscape
BY ROBIN ROBINSON One of the driving factors to find new new solutions is the looming loss of patent protection for several blockbuster drugs. “We are two years away from Lipitor going off patent, which means we are one year closer to Armageddon, and things are going to get really ugly,” says Mat...
By Robin Robinson • May 27, 2008 -
PharmaVoice Team/PharmaVoice
Reaching Patients in the Pharmacy
BY ROBIN ROBINSON It’s not an emerging trend, because it has been in practice for years. It’s not exactly a growing trend, because although there has been more uptake, it is still “underutilized” as a marketing medium. However, pharma companies that use DTC programs at the pharmacy level have fou...
By Robin Robinson • May 27, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Dr. Nancy JOSEPHRIDGE Alan MACKENZIE Takeda Unveils PostTAP Executive Structure Takeda Pharmaceuticals North America (TPNA), Deerfield, Ill., has announced leader ship changes as part of the closing of TAP Pharmaceutical Products, the U.S.based joint venture between Abbott Laboratorie...
By PharmaVoice Team • May 27, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES ForteBio has launched the Octet RED System, an affordable, user friendly tool for labelfree, realtime kinetic analysis of small molecules, peptides, and proteins for research, development, and bio processing. The system is based on...
By PharmaVoice Team • May 27, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
As patients live longer and are increasingly diagnosed with chronic and often debilitating ailments, pharmaceutical decisionmakers find themselves examining ways to adapt their organizations to address the resulting healthcare needs in both human and business terms. According to the report, the p...
By PharmaVoice Team • May 27, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Here is an issue that has eluded the industry since its inception: how do physicians and patients really speak with one another in office visits? It is a question many people have asked, but few have answered. There is an absolute need to understand how physicians and patients actually interact w...
By Meaghan Onofrey • May 27, 2008 -
PharmaVoice Team/PharmaVoice
UpFront
THE OTC MARKET Plop,Plop, Fizz, Fizz Consumers are taking an increasingly active role in self medication because of rising healthcare costs, a large uninsured population, and ever more choices in OTC products. Purchasing OTC drugs also is more convenient and money is saved avoiding doctor’s visit...
By PharmaVoice Team • May 27, 2008 -
PharmaVoice Team/PharmaVoice
Raise your voice: Letters
Digital Training With the emergence of digital technology as the fastest growing means of delivering brand marketing and messaging, digital training is one of the best investments agencies can make to address the increasing pressures and speed of change cited by so many of your experts in the Apr...
By PharmaVoice Team • May 27, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
It’s that time of year again, what we jokingly refer to as “conference season.” As everyone heads into several months of exhibitions, informative sessions, and symposia with lanyards in tow, we thought it would be a good idea to provide some best practices for getting the most out of your confere...
By Taren Grom • May 27, 2008 -
PharmaVoice Team/PharmaVoice
A View on Sales — A Year ofTransformation
6 May 20 08 VIEW on Sales THE FORUM FROM GENERALISTS TO SPECIALISTS Pharma salesforces already have made some moves toward greater therapeutic specialization, in part because physicians have expressed a marked preference for specialty sales reps. According to data from Verispan, most physicians p...
By PharmaVoice Team • May 7, 2008 -
PharmaVoice Team/PharmaVoice
Today's Preceptorship: Staying Afloat Without the Sale
24 May 20 08 VIEW on Sales TRAINING MODELS et’s face it, the word “preceptorship” has gotten a bad rap. And it’s no wonder, considering the boatload of codes, guidelines, standards — and lawsuits — that have reached our industry shores in recent years. Paying clinicians to educate has become a gu...
By PharmaVoice Team • May 7, 2008 -
PharmaVoice Team/PharmaVoice
Making It Stick: How to Maximize Knowledge Retention
22 May 20 08 VIEW on Sales TRAINING MODELS T oo often, training leaders simply develop and conduct training that supports an organizational initiative — launch of a new product, release of a new messaging campaign, strategy to blunt a new competitor, rollout of a new sales force automation solu t...
By PharmaVoice Team • May 7, 2008 -
PharmaVoice Team/PharmaVoice
Driving Sales Excellence Through Competency Modeling
20 May 20 08 VIEW on Sales TALENT DEVELOPMENT I n the increasingly competitive marketplace of the pharmaceutical industry, a high performance salesforce is perhaps the most critical source of competitive advantage.Attracting and selecting the right tal ent is essential to success, given both curr...
By PharmaVoice Team • May 7, 2008 -
PharmaVoice Team/PharmaVoice
Transitioning to a Successful Service Model
18 May 20 08 VIEW on Sales SALES MODELS Some companies already have made significant progress in delivering the right experiences to drive strong relationships. In the US, Novartis earns the highest rep relationship scores, followed by Pfizer, Merck, Glaxo SmithKline, and SanofiAventis. Novartis ...
By PharmaVoice Team • May 7, 2008 -
PharmaVoice Team/PharmaVoice
Sustaining the Pharmaceutical Industry's New Selling Model
16 May 20 08 VIEW on Sales LEARNING MODELS I n the pharmaceutical industry, healthcare providers insist: “we want value during every interaction with sales representatives.” Value comes in fluency of message. Successful training drives the ability to intuitively use skills learned. The traditiona...
By PharmaVoice Team • May 7, 2008 -
PharmaVoice Team/PharmaVoice
Time for a New Educational Standard
14 May 20 08 VIEW on Sales EDUCATIONAL STANDARDS F or years, the relationship between pharmaceutical sales repre sentatives and physicians has been considered one of mutual trust and value. But an increasingly organized movement toward restricting pharmaceutical sales and marketing activities is ...
By PharmaVoice Team • May 7, 2008 -
PharmaVoice Team/PharmaVoice
Supplier Showcase
Showcase 28 May 20 08 VIEW on Sales Campbell Alliance 8045 Arco Corporate Dr. Ste. 500 Raleigh, NC 27617 Phone: 8882972001 www.campbellalliance.com Management Consultants in Pharmaceuticals and Biotech Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical ...
By PharmaVoice Team • May 7, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
good sales representatives is a dedication to their profession and having detailed knowledge about their products, the industry, and the mar ket. Many in the industry say that the role of the sales rep will evolve from being a sample deliv ery person — one of the negative aspects of having an ove...
By PharmaVoice Team • May 7, 2008
Previous
